299 related articles for article (PubMed ID: 9548744)
1. The DNA intercalating alkaloid cryptolepine interferes with topoisomerase II and inhibits primarily DNA synthesis in B16 melanoma cells.
Bonjean K; De Pauw-Gillet MC; Defresne MP; Colson P; Houssier C; Dassonneville L; Bailly C; Greimers R; Wright C; Quetin-Leclercq J; Tits M; Angenot L
Biochemistry; 1998 Apr; 37(15):5136-46. PubMed ID: 9548744
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of topoisomerase II-mediated DNA cleavage by three DNA-intercalating plant alkaloids: cryptolepine, matadine, and serpentine.
Dassonneville L; Bonjean K; De Pauw-Gillet MC; Colson P; Houssier C; Quetin-Leclercq J; Angenot L; Bailly C
Biochemistry; 1999 Jun; 38(24):7719-26. PubMed ID: 10387011
[TBL] [Abstract][Full Text] [Related]
3. DNA intercalation, topoisomerase II inhibition and cytotoxic activity of the plant alkaloid neocryptolepine.
Bailly C; Laine W; Baldeyrou B; De Pauw-Gillet MC; Colson P; Houssier C; Cimanga K; Van Miert S; Vlietinck AJ; Pieters L
Anticancer Drug Des; 2000 Jun; 15(3):191-201. PubMed ID: 11049087
[TBL] [Abstract][Full Text] [Related]
4. The plant alkaloid usambarensine intercalates into DNA and induces apoptosis in human HL60 leukemia cells.
Dassonneville L; Wattez N; Mahieu C; Colson P; Houssier C; Frederich M; Tits M; Angenot L; Bailly C
Anticancer Res; 1999; 19(6B):5245-50. PubMed ID: 10697543
[TBL] [Abstract][Full Text] [Related]
5. Substitution at the F-ring N-imide of the indolocarbazole antitumor drug NB-506 increases the cytotoxicity, DNA binding, and topoisomerase I inhibition activities.
Bailly C; Qu X; Chaires JB; Colson P; Houssier C; Ohkubo M; Nishimura S; Yoshinari T
J Med Chem; 1999 Jul; 42(15):2927-35. PubMed ID: 10425102
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity and nucleic acid binding properties of dercitin, a new acridine alkaloid isolated from a marine Dercitus species sponge.
Burres NS; Sazesh S; Gunawardana GP; Clement JJ
Cancer Res; 1989 Oct; 49(19):5267-74. PubMed ID: 2548717
[TBL] [Abstract][Full Text] [Related]
7. The antimalarial and cytotoxic drug cryptolepine intercalates into DNA at cytosine-cytosine sites.
Lisgarten JN; Coll M; Portugal J; Wright CW; Aymami J
Nat Struct Biol; 2002 Jan; 9(1):57-60. PubMed ID: 11731803
[TBL] [Abstract][Full Text] [Related]
8. In vitro genotoxicity of the West African anti-malarial herbal Cryptolepis sanguinolenta and its major alkaloid cryptolepine.
Ansah C; Khan A; Gooderham NJ
Toxicology; 2005 Mar; 208(1):141-7. PubMed ID: 15664441
[TBL] [Abstract][Full Text] [Related]
9. Synthetic cryptolepine inhibits DNA binding of NF-kappaB.
Olajide OA; Heiss EH; Schachner D; Wright CW; Vollmar AM; Dirsch VM
Bioorg Med Chem; 2007 Jan; 15(1):43-9. PubMed ID: 17064915
[TBL] [Abstract][Full Text] [Related]
10. Intercalation into DNA is not required for inhibition of topoisomerase I by indolocarbazole antitumor agents.
Bailly C; Dassonneville L; Colson P; Houssier C; Fukasawa K; Nishimura S; Yoshinari T
Cancer Res; 1999 Jun; 59(12):2853-60. PubMed ID: 10383146
[TBL] [Abstract][Full Text] [Related]
11. Ethnobotanical-directed discovery of the antihyperglycemic properties of cryptolepine: its isolation from Cryptolepis sanguinolenta, synthesis, and in vitro and in vivo activities.
Bierer DE; Fort DM; Mendez CD; Luo J; Imbach PA; Dubenko LG; Jolad SD; Gerber RE; Litvak J; Lu Q; Zhang P; Reed MJ; Waldeck N; Bruening RC; Noamesi BK; Hector RF; Carlson TJ; King SR
J Med Chem; 1998 Mar; 41(6):894-901. PubMed ID: 9526563
[TBL] [Abstract][Full Text] [Related]
12. DNA cleavage by topoisomerase I in the presence of indolocarbazole derivatives of rebeccamycin.
Bailly C; Riou JF; Colson P; Houssier C; Rodrigues-Pereira E; Prudhomme M
Biochemistry; 1997 Apr; 36(13):3917-29. PubMed ID: 9092822
[TBL] [Abstract][Full Text] [Related]
13. Cryptolepis sanguinolenta: antimuscarinic properties of cryptolepine and the alkaloid fraction at M1, M2 and M3 receptors.
Rauwald HW; Kober M; Mutschler E; Lambrecht G
Planta Med; 1992 Dec; 58(6):486-8. PubMed ID: 1484884
[TBL] [Abstract][Full Text] [Related]
14. DNA but not topoisomerases is a target for a cytotoxic benzo[5,6]cyclohepta[b]indol-6-one derivative.
Benoit J; Routier S; Mérour JY; Colson P; Houssier C; Bailly C
Anticancer Res; 2000; 20(5A):3307-14. PubMed ID: 11062758
[TBL] [Abstract][Full Text] [Related]
15. Cryptolepine hydrochloride: a potent antimycobacterial alkaloid derived from Cryptolepis sanguinolenta.
Gibbons S; Fallah F; Wright CW
Phytother Res; 2003 Apr; 17(4):434-6. PubMed ID: 12722159
[TBL] [Abstract][Full Text] [Related]
16. Relationships between topoisomerase II inhibition, sequence-specificity and DNA binding mode of dicationic diphenylfuran derivatives.
Bailly C; Dassonneville L; Carrasco C; Lucas D; Kumar A; Boykin DW; Wilson WD
Anticancer Drug Des; 1999 Feb; 14(1):47-60. PubMed ID: 10363027
[TBL] [Abstract][Full Text] [Related]
17. Eukaryotic DNA topoisomerases mediated DNA cleavage induced by a new inhibitor: NSC 665517.
Gupta M; Abdel-Megeed M; Hoki Y; Kohlhagen G; Paull K; Pommier Y
Mol Pharmacol; 1995 Oct; 48(4):658-65. PubMed ID: 7476891
[TBL] [Abstract][Full Text] [Related]
18. Novel antitumor indenoindole derivatives targeting DNA and topoisomerase II.
Bal C; Baldeyrou B; Moz F; Lansiaux A; Colson P; Kraus-Berthier L; Léonce S; Pierré A; Boussard MF; Rousseau A; Wierzbicki M; Bailly C
Biochem Pharmacol; 2004 Nov; 68(10):1911-22. PubMed ID: 15476662
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity and cell cycle effects of the plant alkaloids cryptolepine and neocryptolepine: relation to drug-induced apoptosis.
Dassonneville L; Lansiaux A; Wattelet A; Wattez N; Mahieu C; Van Miert S; Pieters L; Bailly C
Eur J Pharmacol; 2000 Dec; 409(1):9-18. PubMed ID: 11099695
[TBL] [Abstract][Full Text] [Related]
20. Isoneocryptolepine, a synthetic indoloquinoline alkaloid, as an antiplasmodial lead compound.
Van Miert S; Hostyn S; Maes BU; Cimanga K; Brun R; Kaiser M; Mátyus P; Dommisse R; Lemière G; Vlietinck A; Pieters L
J Nat Prod; 2005 May; 68(5):674-7. PubMed ID: 15921407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
